Cargando…

Testing for SARS-CoV-2 infection: a key strategy to keeping schools and universities open

Detalles Bibliográficos
Autores principales:	Koirala, Archana, Wood, Nicholas, Macartney, Kristine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979150/ https://www.ncbi.nlm.nih.gov/pubmed/33751953 http://dx.doi.org/10.1016/S2352-4642(21)00087-0

Ejemplares similares

Daily antigen testing to reduce disruption when schools return
por: Viner, Russell M, et al.
Publicado: (2021)

Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia
por: Wood, Nicholas, et al.
Publicado: (2023)

The role of schools and school-aged children in SARS-CoV-2 transmission
por: Flasche, Stefan, et al.
Publicado: (2021)

SARS-CoV-2: eye protection might be the missing key
por: Coroneo, Minas Theodore, et al.
Publicado: (2021)

The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
por: Carsetti, Rita, et al.
Publicado: (2020)

Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2
por: Pitzer, Virginia E, et al.
Publicado: (2020)

Mitochondrial DNA keeps you young
por: Bonora, Massimo, et al.
Publicado: (2018)

Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
por: Macartney, Kristine, et al.
Publicado: (2020)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

We need to keep an eye on avian influenza
por: Krammer, Florian, et al.
Publicado: (2023)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2
por: Zhang, Yi, et al.
Publicado: (2020)

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy
por: Jensen, Jeffrey D., et al.
Publicado: (2020)

Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
por: Flanagan, Katie L., et al.
Publicado: (2020)

Keeping sight of copper in single-atom catalysts for electrochemical carbon dioxide reduction
por: Creissen, Charles E., et al.
Publicado: (2022)

Public financing for primary health care is the key to universal health coverage and strengthening health security
por: Brundtland, Gro Harlem
Publicado: (2022)

SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings
por: Boehme, Catharina, et al.
Publicado: (2021)

Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
por: Mina, Michael J, et al.
Publicado: (2021)

SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission
por: Fearon, Elizabeth, et al.
Publicado: (2021)

Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant
por: Lopez, Laura, et al.
Publicado: (2022)

Modelling results on the impact of COVID-19 testing in schools
por: Dyson, Louise
Publicado: (2022)

Targeted mass testing and phylogenetic analysis is effective for preventing community transmission of SARS‐CoV‐2 beta variant
por: Tokuda, Yasuharu, et al.
Publicado: (2022)

Genetic Counsellors play a key role in supporting ethically responsible expanded universal carrier screening
por: Dive, Lisa, et al.
Publicado: (2022)

University of California Medical School Seminars
Publicado: (1941)

I am having trouble keeping up with virtual teaching activities: Reflections in the COVID-19 era
por: Machado, Renato Assis, et al.
Publicado: (2020)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021
por: Koirala, Archana, et al.
Publicado: (2022)

Indonesian first national suicide prevention strategy: key findings from the qualitative situational analysis
por: Onie, Sandersan, et al.
Publicado: (2023)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

How persistent stigma and discrimination keep people with visible skin diseases out of jobs: vitiligo in Brazil today
por: Silveira, Luísa Polo, et al.
Publicado: (2023)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Sustainability of surveillance systems for SARS-CoV-2
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jg7r1i6vo3ubg7lqfqpm2fjp7k